Book a free demo with us
Book Now
Lucidity Insights

DreaMed Diabetes

AI that transforms patient data into expert level treatment recommendations. DreaMed technology is cleared by the FDA, so care providers and patients can trust the treatment recommendations generated are at an expert level.

Total Fundraised$5B

PE Round
Late Stage
Debt Financing
Pre-IPO
Series C
Series B
Series A
Others
Calendar Image2014
Established
HeadquarterGradient ImagePetah Tikva, Israel
Headquarter
OperationalGradient Image
ISR
Operational Market
SectorGradient Image
Artificial Intelligence
Medical Device
Enterprise Software
Healthcare
Primary Sector
EmployeeGradient Image -
Employees
GlobeGradient Imagehttps://dreamed.ai/
Website

Funding Types by Funds Raised (in USD)

Content Locked

Login or Register a FREE account to continue browsing our content

Cumulative Funding Raised Over Time

Content Locked

Login or Register a FREE account to continue browsing our content

DreaMed Diabetes's Investors by Funding Rounds

Funding Round

Announced Date

Disclosed Investors

Round Amount (USD)

Content Locked

Login or Register a FREE account to continue browsing our content

Related Startups

V-Wave

Drapp

Thakaa Med

Discure Technologies

Sensi.Ai

About

CompanyCareersContact & Support

Legal

Privacy PolicyTerms of ServiceDo Not Sell My InfoAttribution Instructions
Book a free demo with us
Lucidity InsightsLucidity InsightsLucidity InsightsLucidity Insights
© 2024 Lucidity Insights.